DS

Dayanand Singh

Active Director Director DIN 11460589
DIN 11460589 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Dayanand Singh

Data last updated:

Dayanand Singh is a Director at Hajua Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11460589
Primary Designation Director
Industry Pharma
First Appointment 02 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Jan 20262026Active

Board colleagues of Dayanand Singh

NameDINCompanyDesignation
Arvind Kumar Singh07878973Hajua Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hajua Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Dayanand Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dayanand Singh

Dayanand Singh currently holds 1 directorship: Hajua Pharmaceuticals Private Limited (Director, since 02 Jan 2026).

Dayanand Singh was first appointed on 02 Jan 2026 as Director at Hajua Pharmaceuticals Private Limited.

The current boards of Dayanand Singh's companies include Arvind Kumar Singh (Hajua Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available